◼ Archived
Business
Roche Drug Candidate Hits Target in Late-Stage Study for Autoimmune Disease
Roche's experimental drug sefaxersen meets its primary endpoint in a late-stage study for the autoimmune disease IgAN.
Igan
1 trends tracked about this subject — the full history, oldest to newest below.